603360.SS
603360.SS
CNE100002Z24
DALIAN BIO-CHEM CO LTD
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 80/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±48.5% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.1x).

Beta (Market Relation)
0.14x
Defensive
Volatility (5Y p.a.)
48.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-69.5%
5-Year Horizon
Sharpe Ratio
0.37
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -54.6%
3 Years 55.4% -69.5% 0.51 +30.9%
5 Years 48.5% -69.5% 0.37 +20.5%
10 Years 47.8% -69.5% 0.29 —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 48.0 (Elevated multiple compression risk)
Strong cyclicality: The business model is sensitive to economic downturns.
Elevated Short-Term Volatility: 3Y volatility (55.4%) is noticeably higher than the 5Y average (48.5%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (48.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -69.5% in the extended horizon.
ende